Antimicrobial Resistance Conference

A veterinary epidemiologist with diverse research interests including antibiotic resistance, microbial ecology, livestock production microbiomes, metagenomics, antibiotic use in veterinary medicine, bioinformatics and statistics.

Awards & recognition

• IonE Associate
• USDA AFRI ELI Post-Doctoral Fellow
• NIH T32 Pre-Doctoral Fellow
• Sustainability Leadership Fellow
• Alexander von Humboldt German Chancellor Fellow

Dr. Plummer’s clinical specialty is internal medicine and infectious disease of ruminants.  He has been board certified in Large Animal Internal Medicine by the American College of Veterinary Internal Medicine since 2004.  He is also the only individual in the United States (and one of only two in North America) who is board certified by the European College of Small Ruminant Health Management (the only specialty board for sheep and goats in the world).  Dr. Plummer is the principal investigator leading an independent extramurally funded research laboratory with a significant focus on zoonotic pathogens of livestock, antimicrobial resistance/stewardship/use and livestock welfare. Dr. Paul Plummer also serves as the executive director of the National Institute of Antimicrobial Resistance Research and Education (NIAMRRE, niamrre.org), housed at the Iowa State University Research Park.

Elizabeth S. Dodds is an Associate Professor of Medicine with the Division of Infectious Diseases and International Health at Duke University. She serves as the Director of Operations and liaison pharmacist with the Duke Antimicrobial Stewardship Outreach Network (DASON). She received her Doctor of Pharmacy degree from the Bouvé College of Pharmacy and Health Sciences at Northeastern University, Boston, Massachusetts, graduating Summa Cum Laude. She subsequently completed her pharmacy practice residency at Duke University Health System and a specialty residency in adult internal medicine/infectious disease with Duke University Health System and Campbell University before joining the Department of Medicine at Duke University Medical Center. In 2006 she completed her Masters in Health Science in Clinical Research at Duke University School of Medicine. 

Antimicrobial stewardship has been the focus of Dr. Dodds Ashley’s clinical and research activities for nearly 20 years. Her experience includes managing antimicrobial stewardship programs at large academic medical centers as well as collaborating and guiding programs for small community hospitals and healthcare systems. 

Dr. Robinson received his early education at the University of NSW, Sydney Australia where he received a B.Sc. (Hons), M.Sc. and Ph.D. degrees. He was a postdoctoral fellow in the University of Michigan Medical School then a junior faculty in the School of Pathology prior to moving to Purdue University where he was promoted to full professor in 1993.

Dr. Robinson is currently the Distinguished Professor of Cytometry, in Basic Medical Sciences, and Professor of Biomedical Engineering in the Weldon School of Biomedical Engineering. Dr. Robinson is a Fellow of the American Institute for Medical and Biological Engineering, the American Association for the Advancement of Science, the National Academy of Inventors and the Royal Society for Microbiology.  Dr. Robinson is a past president of the International Society for Advancement of Cytometry and is the past Editor-in-Chief of Current Protocols in Cytometry.

Paul Ebner’s career as a professor of animal sciences and his commitment to international extension both started to take shape in a South American village that had neither electricity nor running water. After earning an undergraduate degree in political science at Kalamazoo College, Ebner became a Peace Corps Volunteer in Paraguay.

Farm animals weren’t a common sight in his home city of Livonia, Michigan, a suburb of Detroit, but on another continent in a place dependent on nonmechanized agriculture, Ebner began to recognize the importance of livestock production.

He completed master’s and doctoral degrees in animal science at the University of Tennessee and a postdoc in microbiology and immunology at the Louisiana State University Health Sciences Center.

Metabolomics Analyst

Christina Ferreira had training in veterinary medicine at the State University of Sao Paulo and started doing research in molecular biology and animal biotechnology. In 2008 Christina started post-doctoral training at the University of Campinas - Brazil in mass spectrometry focused on the area of culture media metabolomics and lipidomics of embryonic early development. In 2010 she came to Purdue University to work with Graham Cooks on diverse projects with lipid analysis and in Parkinson's disease biomarker search in cerebrospinal fluid. Due to her chemical-biological background, Christina has developed and introduced diverse tailored analytical approaches. Christina will work together with Metabolite Profiling Facility faculty and users on high-throughput metabolomics analysis focused on lipid profiling.

Associate Professor of Industrial and Molecular Pharmaceutics

Specialization: Pharmaceutical manufacturing of solid dosage forms, particle engineering, powder technology, surface characterization of pharmaceutical solids, inhalation formulation, pulmonary drug delivery system, dry powder inhaler

Research

Dr. Zhou’s research focuses on: (1) particle engineering for innovative pharmaceutical manufacturing of solid dosage forms; (2) advanced characterization of pharmaceutical solids; (3) novel formulation design for pulmonary drug delivery systems.

Education

2013-2015 NHMRC Early Career Fellow (=NIH K01), University of Sydney, Australia
2012-2013 Postdoctoral Research Fellow, University of Sydney, Australia
2011-2012 Postdoctoral Research Fellow, Monash University, Australia
2007-2011 PhD in Pharmacy, Monash University, Australia
2004-2008 MSc in Pharmacy, National University of Singapore, Singapore
1997-2001 BEng in Pharmaceutics, Shenyang Pharmaceutical University, China

D.V.M., Colorado State University
M.P.H., Environmental Health Sciences, Yale University
B.S., Environmental Science & Chemistry, Muhlenberg College

I am a veterinarian with a background in public health and epidemiology. My ultimate goal is to advance understanding of the ways in which ecosystems, farm environments, and general agricultural management practices influence occurrence of disease in human and animal populations. To that end, my research interests involve the development of laboratory, computational, and statistical methods necessary to characterize potential risks of mobilization of antimicrobial resistance genes between pathogens at the human-animal interface. Currently, my research projects are being conducted in the U.S., Europe, and Africa.

Associate Professor, Department of Biochemistry, Purdue University

Hall lab research interests:

• Identification of new candidate antifungal drug targets, focusing on the Candida pathogenic yeasts.
• Characterization of phosphatases and kinases that play important roles in regulating fungal-specific aspects of the cell division cycle
• Developing tools that combine inducible protein degradation technologies with in vivo infection models or proteomics to help identify new drug targets and characterize phosphatases and kinases in fungal pathogens.

Professor - Organic Chemistry

Education

B.S., California Institute of Technology, 1989

Ph.D., Harvard University, 1995

Fulbright Scholar, University Louis Pasteur, 1996

Chateaubriand Postdoctoral Fellow, University Louis Pasteur, 1997

Awards

2023:        Hovey Lecturer (Wabash College, IN)

2020:        President’s Safety Award (Purdue Univ., IN)

2018:        Jean Dreyfus Lectureship (Towson Univ., MD)

2013:        Discovery Park Fellow (Purdue Univ.)

2008:       Birck Nanotechnology Center Research Citation Award (Purdue Univ.)

2007:       University Faculty Scholar (Purdue Univ.)

2005:       JSPS Fellow (NIMS, Tsukuba, Japan)

1996:       Chateaubriand Postdoctoral Fellow (Univ. Strasbourg, France)

1995:       Fulbright Scholar (Univ. Strasbourg, France)

Our research program employs organic and nanomaterials synthesis to address various topics that can impact human health. Our expertise includes agents for photodynamic therapy, stimuli-responsive dyes for fluorescent imaging, surface conjugation and functionalization, and novel targeted drug delivery mechanisms. Applications include the targeted delivery of inorganic and micellar nanoparticles for photodynamic and combination therapies, ligand-conjugated surfaces and nanostructures for bacterial detection and targeting, and the chemical imaging of intracellular processes.

Dr. Tingting Ju is an assistant professor in the Department of Animal Sciences at Purdue University. She completed her PhD and continued her postdoctoral training at the University of Alberta studying the role of gut commensal microbes and host-microbe interactions. The goals of Dr. Ju’s research program are to (i) understand the role of commensal microbes in regulating host physiology in livestock animals and (ii) implement strategies to improve animal performance and health via manipulating the gut microbiota. By establishing effective models and using an array of techniques including gnotobiotic animal models and high throughput molecular techniques, she focused on the complex dynamics of gut microbial ecosystem and mechanisms through which key microbial players regulate host physiology. To move toward AGP-free in animal production systems, understanding the microbial-host interactions holds promise for developing new strategies to improve health, metabolism, and disease resistance in animals.

Dr. Flaherty received a Bachelor of Arts in chemistry from Central College in Pella, IA. He then moved on to earn his PhD in pharmaceutical sciences under the direction of Dr. Jonathan Vennerstrom at the University of Nebraska Medical Center. Following his graduate studies he moved to the University of Kansas and joined an NIH sponsored medicinal chemistry lab under the direction of Dr. Jeffrey Aubé as a post-doctoral researcher and later as a research track faculty. He is now an assistant professor in the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University with interests in developing small molecule inhibitors using structure-based design for under-explored biomolecular targets. His research focuses on validating novel therapeutic targets for treatment in infectious disease, cancer, and neurodegenerative disease.